Posted on February 1, 20212/1/21
Iterum Therapeutics Announces Collaboration with EVERSANA to Support Oral Sulopenem Launch
Posted on August 10, 20208/10/20
FDA Approves Roche, PTC’s SMA Treatment, Evrysdi (Risdiplam)
Posted on June 11, 20206/11/20
FDA Approves BMS’ Opdivo for Advanced ESCC After Chemotherapy
Posted on June 3, 20206/3/20
FDA Sets September Review Date for Novartis’ Multiple Sclerosis Targeted B-Cell Therapy, Ofatumumab
Posted on May 26, 20205/26/20
FDA Grants Enhertu Orphan Drug Designation for Gastric Cancer
Posted on May 11, 20205/11/20
FDA OK’s AZ & Merck’s Lynparza Plus Bevacizumab in HRD-Positive Ovarian Cancer
Posted on April 8, 20204/8/20
FDA Grants Priority Review to Merck’s Keytruda, Use Based on Biomarker Regardless of Tumor Type
Posted on February 23, 20202/23/20